About VivoSense
VivoSense is a company based in San Diego (United States) founded in 2010 by Dudley Tabakin and Lance Myers. VivoSense has raised $27.46 million across 6 funding rounds from investors including Debiopharm and Perceptive Advisors. VivoSense offers products and services including Wearable Sensor Services, Design and Configure, Data Collection and Cleaning, and Insight Delivery. VivoSense operates in a competitive market with competitors including Curebase, L7 Informatics, MDClone, Clinical Research IO and THREAD, among others.
- Headquarter San Diego, United States
- Founders Dudley Tabakin, Lance Myers
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$27.46 M (USD)
in 6 rounds
-
Latest Funding Round
$25 M (USD), Series A
Mar 04, 2022
-
Investors
Debiopharm
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VivoSense
VivoSense offers a comprehensive portfolio of products and services, including Wearable Sensor Services, Design and Configure, Data Collection and Cleaning, and Insight Delivery.
End-to-end implementation of wearable tech for clinical trials.
Tools for designing wearable sensor setups in research.
Services to generate and clean sensor data for trials.
Interpreting sensor data to deliver actionable insights.
People of VivoSense
Unlock access to complete
Software Development Team
4 people
Leadership Team
4 people
Project Team
1 people
Senior Team
1 people
Unlock access to complete
Funding Insights of VivoSense
VivoSense has successfully raised a total of $27.46M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $25 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in VivoSense
VivoSense has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Debiopharm and Perceptive Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Biopharmaceutical company focused on oncology, infectious diseases, and orphan drugs
|
Locked | Locked | Locked |
Investor details for VivoSense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VivoSense
Investment portfolio details for VivoSense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VivoSense
Detailed financials for VivoSense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vivosense Comparisons
Peer comparison for VivoSense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VivoSense
VivoSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curebase, L7 Informatics, MDClone, Clinical Research IO and THREAD, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Patient enrollment platform for decentralized clinical research is provided.
|
|
| Locked | Locked | Locked |
Clinical trial workflow management software is provided for laboratories.
|
|
| Locked | Locked | Locked |
Provider of software that creates synthetic medical records for fictitious patients
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for research sites.
|
|
| Locked | Locked | Locked |
Provider of patient research studies software
|
Detailed competitors of VivoSense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vivosense
Complete news archive for VivoSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VivoSense
VivoSense was founded in 2010 and raised its 1st funding round 7 years after it was founded.
VivoSense is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Dudley Tabakin is the current CEO of VivoSense. They have also founded this company.
VivoSense is a funded company, having raised a total of $27.46M across 6 funding rounds to date.
VivoSense was established in 2010 in San Diego, United States, within the health technology sector focused on clinical research. Wearable sensor solutions, data analysis services, and algorithm development are provided by Vivonoetics for trials involving data collection. The VivoSense platform supports analysis across disease states such as sleep disordered breathing, congestive heart failure, and cystic fibrosis. Over 500 pharmaceutical, research, and academic institutions have utilized these services globally.
VivoSense's top competitors include L7 Informatics, Curebase and Sonrai Analytics.
VivoSense offers Wearable Sensor Services, Design and Configure, Data Collection and Cleaning, and Insight Delivery.
VivoSense has 2 investors. Key investors include Debiopharm, and Perceptive Advisors.